Holen Sie sich die Stockscreener-App
1.00
5.26%
0.05
Finanzdaten der Fibrobiologics Inc-Aktie (FBLG)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
20.42%
4.033
|
5.068 | 2.59 | 5.038 | 4.49 |
| Operating Income/Loss |
20.42%
-4.033
|
-5.068 | -2.59 | -5.038 | -4.49 |
| Nonoperating Income/Loss |
223.53%
-0.084
|
0.068 | -0.654 | -0.74 | - |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
17.66%
-4.117
|
-5.00 | -3.244 | -5.778 | -4.658 |
| Basic Average Shares |
66.25%
6.2725
|
3.7729 | 5.1728 | 43.07 | 38.64 |
| Diluted Average Shares |
66.25%
6.2725
|
3.7729 | 5.1728 | 43.07 | 38.64 |
| Basic Earnings Per Share |
50.38%
-0.66
|
-1.33 | -0.03 | -0.13 | -0.12 |
| Diluted Earnings Per Share |
50.38%
-0.66
|
-1.33 | -0.03 | -0.13 | -0.12 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):